311 related articles for article (PubMed ID: 34836718)
1. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
3. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
5. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
6. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
7. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
[TBL] [Abstract][Full Text] [Related]
8. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
9. Insights into anti-tumor immunity
Jani S; Church CD; Nghiem P
Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
[TBL] [Abstract][Full Text] [Related]
10. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
14. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
[TBL] [Abstract][Full Text] [Related]
15. Decreased H3K27me3 Expression Is Associated With Merkel Cell Polyomavirus-negative Merkel Cell Carcinoma, Especially Combined With Cutaneous Squamous Cell Carcinoma.
Matsushita M; Iwasaki T; Wardhani LO; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Anticancer Res; 2019 Oct; 39(10):5573-5579. PubMed ID: 31570452
[TBL] [Abstract][Full Text] [Related]
16. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
[TBL] [Abstract][Full Text] [Related]
17. Detection of Polyomavirus in Merkel cell carcinoma by immunohistochemistry: report of three cases.
Vaira F; Nazzaro G; Pesapane F; Brambilla L; Coggi A; Fanoni D; Venegoni L; Tourlaki A; Gianotti R; Berti E
G Ital Dermatol Venereol; 2015 Oct; 150(5):617-21. PubMed ID: 26333556
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: a review.
Verzì AE; Amin SM; Guitart J; Micali G
G Ital Dermatol Venereol; 2015 Aug; 150(4):419-28. PubMed ID: 26224231
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
[TBL] [Abstract][Full Text] [Related]
20. A review on the oncogenesis of Merkel cell carcinoma: Several subsets arise from different stages of differentiation of stem cell.
Zhu Y; Yin Y; Li F; Ren Z; Dong Y
Medicine (Baltimore); 2023 Apr; 102(15):e33535. PubMed ID: 37058042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]